|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-7-17
|
|
pubmed:abstractText |
Vinorelbine and gemcitabine are two active single agents used in the treatment of non-small cell lung cancer (NSCLC). A clinical trial was conducted to evaluate the efficacy and toxicity of vinorelbine plus gemcitabine in patients with inoperable (stage IIIB or IV) NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
117
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1583-9
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:10858387-Adult,
pubmed-meshheading:10858387-Aged,
pubmed-meshheading:10858387-Aged, 80 and over,
pubmed-meshheading:10858387-Antimetabolites, Antineoplastic,
pubmed-meshheading:10858387-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:10858387-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10858387-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10858387-Deoxycytidine,
pubmed-meshheading:10858387-Dose-Response Relationship, Drug,
pubmed-meshheading:10858387-Drug Administration Schedule,
pubmed-meshheading:10858387-Female,
pubmed-meshheading:10858387-Humans,
pubmed-meshheading:10858387-Infusions, Intravenous,
pubmed-meshheading:10858387-Lung Neoplasms,
pubmed-meshheading:10858387-Male,
pubmed-meshheading:10858387-Middle Aged,
pubmed-meshheading:10858387-Palliative Care,
pubmed-meshheading:10858387-Vinblastine
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.
|
|
pubmed:affiliation |
Chest Department, Veterans General Hospital-Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
